Lori Panther

Lori Panther

Company: Moderna, Inc

Job title: Vice President, Clinical Development, Infectious Diseases

Seminars:

Live Panel Q&A – Ask Speakers your Burning Questions 10:40 am

Read more

day: Day One

Messenger RNA (mRNA) Vaccine Against Cytomegalovirus (CMV) Infection: Phase 2 Interim Data 9:25 am

A safe and effective vaccine against cytomegalovirus (CMV) infection remains a high priority in the effort to prevent congenital CMV Interim data from a Phase 2, randomized, placebo-controlled, dosefinding trial assessing the safety and immunogenicity of candidate CMV vaccine mRNA-1647 will be presented The interim data indicate that mRNA-1647 is well tolerated and immunogenic, supporting…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.